Business
Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia
Launch complements existing Tweed and Spectrum Therapeutics product portfolio Canopy ...

About this update from Canopy Growth Corporation
[{"type":"text","content":"Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n\n Launch complements existing Tweed and Spectrum Therapeutics product portfolio\n \n\n\n\n\n Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has introduced its Canadian-grown 7ACRES brand in Australia, expanding the Company’s medical cannabis offering with two high-THC sativa strains: Ultra Jack and Jack Frost.\n \n\n Ultra Jack, a cross of Ultra Sour and Jack Haze, is one of 7ACRES’ top performing flower strains in the Canadian medical and adult-use cannabis markets. Jack Frost, a cross of White Widow and Cold Creek Kush, adds further genetic depth to the lineup. Both strains are initially available in 10g flower formats.\n \n\n “Adding 7ACRES to our Australian portfolio helps ensure patients and prescribers have access to a diverse range of high-quality flower options,” said\n \n Andrew Bevan, SVP, Global Medical\n \n . “With recent improvements to our global supply chain, we’re positioned to deliver these strains with consistent quality and reliable access to patients in Australia.”\n \n\n “Global medical is one of Canopy Growth’s largest commercial opportunities,” said\n \n Luc Mongeau, Chief Executive Officer\n \n . “Our ability to scale high-quality production in Canada and reliably supply international markets remains a key strength as we expand our global medical platform.”\n \n\n The introduction of 7ACRES complements Canopy Growth’s existing presence in Australia, which includes Tweed flower products as well as Spectrum Therapeutics oils available in Red, Yellow, White, and Blue formulations. Together, this expanded medical portfolio reflects Canopy Growth’s focus on building a scalable medical platform across international markets.\n \n\n\n About Canopy Growth\n \n\n Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.\n \n\n Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed bran...